SIAS
BBH icon

Shine Investment Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Shine Investment Advisory Services’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-352
Closed -$47K – 651
2017
Q3 		$47K Hold
352
– – 0.02% 307
2017
Q2 		$44K Buy
+352
New +$42.4K 0.02% 297

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Shine Investment Advisory Services's BBH Position: Q4 2017 in Review

Shine Investment Advisory Services sold out of VanEck Biotech ETF (BBH) in Q4 2017, closing a stake of 352 shares — an estimated $47K sold.

Shine Investment Advisory Services first reported a position in BBH in Q2 2017 and held it in 2 quarters. The position peaked at $47K in Q3 2017. 82 funds tracked by Wall St. Rank hold BBH as of Q4 2017.

  • Shine Investment Advisory Services reported no remaining VanEck Biotech ETF position as of Q4 2017 after selling out during the quarter.
  • Shine Investment Advisory Services sold 352 VanEck Biotech ETF shares in Q4 2017, an estimated $47K.
  • Shine Investment Advisory Services first reported a position in VanEck Biotech ETF in Q2 2017 and held it in 2 quarters.
  • Shine Investment Advisory Services's VanEck Biotech ETF position peaked at $47K in Q3 2017.
  • 82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2017.

Based on Shine Investment Advisory Services's 13F filing for Q4 2017, filed 25 Jan 2018.